Heron Therapeutics Shares Outstanding 2006-2019 | HRTX

Heron Therapeutics shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Heron Therapeutics Annual Shares Outstanding
(Millions of Shares)
2018 73
2017 54
2016 38
2015 33
2014 27
2013 16
2012 12
2011 6
2010 2
2009 2
2008 2
2007 1
2006 0
2005 0
Heron Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 78
Q4 2018 73
Q3 2018 78
Q2 2018 72
Q1 2018 65
Q4 2017 54
Q3 2017 54
Q2 2017 54
Q1 2017 51
Q4 2016 38
Q3 2016 39
Q2 2016 37
Q1 2016 36
Q4 2015 33
Q3 2015 36
Q2 2015 31
Q1 2015 29
Q4 2014 27
Q3 2014 29
Q2 2014 24
Q1 2014 24
Q4 2013 16
Q3 2013 15
Q2 2013 15
Q1 2013 15
Q4 2012 12
Q3 2012 14
Q2 2012 10
Q1 2012 10
Q4 2011 6
Q3 2011 10
Q2 2011 2
Q1 2011 2
Q4 2010 2
Q3 2010 2
Q2 2010 2
Q1 2010 2
Q4 2009 2
Q3 2009 2
Q2 2009 2
Q1 2009 2
Q4 2008 2
Q3 2008 2
Q2 2008 2
Q1 2008 2
Q4 2007 1
Q3 2007 2
Q2 2007 0
Q1 2007 0
Q4 2006 0
Q3 2006 0
Q2 2006 0
Q1 2006 0
Q4 2005 0
Q3 2005 0
Q2 2005 0
Q1 2005 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.461B $0.077B
Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.610B 34.89
Astellas Pharma (ALPMY) Japan $28.433B 13.94
Takeda Pharmaceutical (TAK) Japan $27.154B 7.97
UCB SA (UCBJF) Belgium $15.866B 0.00
Eisai (ESALY) Japan $15.807B 27.18
Grifols, S.A (GRFS) Spain $15.209B 19.24
Merck (MKGAF) Germany $13.448B 18.35
IPSEN SA ADR (IPSEY) France $10.783B 0.00
Ionis Pharmaceuticals (IONS) United States $9.649B 21.09
Sage Therapeutics (SAGE) United States $9.439B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Catalent (CTLT) United States $7.912B 31.75
Neurocrine Biosciences (NBIX) United States $7.824B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.738B 10.61
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Nektar Therapeutics (NKTR) United States $5.573B 9.08
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.805B 16.89
Evotec AG (EVTCY) Germany $4.267B 45.80
Tilray (TLRY) Canada $4.238B 0.00
FibroGen (FGEN) United States $3.983B 0.00
United Therapeutics (UTHR) United States $3.300B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.220B 11.56
Arrowhead Pharmaceuticals (ARWR) United States $2.766B 416.71
PTC Therapeutics (PTCT) United States $2.514B 0.00
Xencor (XNCR) United States $2.513B 68.60
Zogenix (ZGNX) United States $2.035B 0.00
Portola Pharmaceuticals (PTLA) United States $1.814B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.658B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.647B 79.76
Enanta Pharmaceuticals (ENTA) United States $1.613B 22.04
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.462B 12.71
Corcept Therapeutics (CORT) United States $1.263B 18.03
ArQule (ARQL) United States $1.158B 0.00
Aerie Pharmaceuticals (AERI) United States $1.062B 0.00
Radius Health (RDUS) United States $1.035B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.016B 3.66
Theravance Biopharma (TBPH) Cayman Islands $0.986B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.879B 0.00
Endo (ENDP) Ireland $0.740B 1.19
Concordia (CXRXF) Canada $0.716B 0.00
Aptorum Group (APM) China $0.636B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.577B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.574B 0.00
Organogenesis Holdings (ORGO) United States $0.562B 0.00
TherapeuticsMD (TXMD) United States $0.543B 0.00
Karyopharm Therapeutics (KPTI) United States $0.505B 0.00
GlycoMimetics (GLYC) United States $0.482B 0.00
ChemoCentryx (CCXI) United States $0.474B 0.00
Translate Bio (TBIO) United States $0.472B 0.00
Akebia Therapeutics (AKBA) United States $0.457B 0.00
Dova Pharmaceuticals (DOVA) United States $0.452B 0.00
Dermira (DERM) United States $0.450B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.444B 22.38
Siga Technologies (SIGA) United States $0.440B 1.04
Catalyst Pharmaceuticals (CPRX) United States $0.417B 0.00
CV Sciences (CVSI) United States $0.413B 0.00
Flexion Therapeutics (FLXN) United States $0.412B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.403B 0.00
CannTrust Holdings (CTST) Canada $0.391B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.390B 0.00
Indivior (INVVY) United States $0.386B 1.39
BioCryst Pharmaceuticals (BCRX) United States $0.374B 0.00
Innate Pharma SA (IPHYF) France $0.364B 0.00
Harpoon Therapeutics (HARP) United States $0.348B 0.00
ImmunoGen (IMGN) United States $0.348B 0.00
Collegium Pharmaceutical (COLL) United States $0.346B 0.00
Xeris Pharmaceuticals (XERS) United States $0.331B 0.00
KalVista Pharmaceuticals (KALV) United States $0.305B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.288B 0.00
Molecular Templates (MTEM) United States $0.272B 0.00
Concert Pharmaceuticals (CNCE) United States $0.256B 0.00
OptiNose (OPTN) United States $0.250B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.236B 0.00
Lannett Co Inc (LCI) United States $0.235B 2.28
Recro Pharma (REPH) United States $0.220B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.215B 0.00
Ocular Therapeutix (OCUL) United States $0.195B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.193B 0.00
Redhill Biopharma (RDHL) Israel $0.178B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 56.63
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Calithera Biosciences (CALA) United States $0.162B 0.00
Ardelyx (ARDX) United States $0.157B 0.00
IMV INC (IMV) Canada $0.152B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.151B 0.00
Jounce Therapeutics (JNCE) United States $0.136B 0.00
Majesco Entertainment (PTE) United States $0.132B 0.00
MEI Pharma (MEIP) United States $0.131B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.131B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.126B 0.00
DURECT (DRRX) United States $0.118B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Generex Biotechnology (GNBT) United States $0.107B 0.00
Aquestive Therapeutics (AQST) United States $0.103B 0.00
MediWound (MDWD) Israel $0.101B 0.00
RENEURON GP (RNUGF) United Kingdom $0.100B 0.00
Iterum Therapeutics (ITRM) Ireland $0.093B 0.00
Infinity Pharmaceuticals (INFI) United States $0.092B 0.00
Mast Therapeutics (SVRA) United States $0.089B 0.00
Champions Oncology (CSBR) United States $0.089B 768.00
Genocea Biosciences (GNCA) United States $0.089B 0.00
Capnia (SLNO) United States $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 63.00
Nivalis Therapeutics (ALPN) United States $0.088B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.086B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.083B 0.00
Aclaris Therapeutics (ACRS) United States $0.082B 0.00
Cardiome Pharma (CORV) Canada $0.080B 0.00
Natural Alternatives (NAII) United States $0.079B 7.90
Otonomy (OTIC) United States $0.077B 0.00
China SXT Pharmaceuticals (SXTC) China $0.075B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.074B 0.00
Novan (NOVN) United States $0.070B 0.00
Neos Therapeutics (NEOS) United States $0.070B 0.00
Pharmaxis (PXSLY) Australia $0.067B 0.00
SCYNEXIS (SCYX) United States $0.066B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.055B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.055B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00